Business ❯ Corporate Communications

Investor Relations

Press Releases Webcasts Financial Reporting Conference Calls Public Relations Company Announcements Public Announcements Earnings Announcements Financial Disclosures Market Reactions

SCYNEXIS Acquires Poxel’s PXL-770 for ADPKD, Plans 2026 Phase 2 Trial

The deal adds a potential disease‑modifying pill for a genetic kidney disorder with few options.

Vallourec Secures Five Indonesian OCTG Contracts Totaling 36,000 Tons

Nordea Discloses CFO Ian Smith’s 31,063-Share Incentive Grant Under EU Market Abuse Rules

Titan America Caps 2025 With Record Earnings and Keystone Cement Agreement

Lumentum Targets $2 Billion Quarterly Run Rate, Secures Major OCS Deal, Outlines Nvidia-Funded Fab Ramp

Rezolve Ai Completes $230 Million All-Cash Acquisition of Reward Loyalty

Brookfield Business Partners and Brookfield Renewable Set Jan. 30 Calls for Q4 2025 Results

Kyverna CAR-T Delivers Positive Phase 2 Topline in Stiff Person Syndrome as Shares Jump

Olema Soars on Roche SERD Win, Then Slips on Planned Stock Offering

CSX Q3 Profit Falls on Goodwill Write-Down, Operations Show Early Gains Under New CEO

FDA Signals Openness to Accelerated Path for Lexeo’s Friedreich’s Ataxia Cardiac Gene Therapy

Hyflux Trial: Defence Casts 'Play Down Energy' as Investor Relations Strategy

Gensol Engineering Faces ED Money Laundering Probe After SEBI Exposes Fund Diversion

Cue Biopharma Finalizes $20 Million Public Offering Ahead of Business Update Call

Twilio Stock Surges 22% Following Optimistic Growth and Profitability Forecast

Centerra Gold Announces Q3 2024 Results Release and Conference Call